Last Chance to Register for the Johnson & Johnson Innovation Digital Health Masterclass

Over 100 of Europe's best digital health companies have already asked to take part in the Johnson & Johnson Digital Health Masterclass and an impressive line up of some of Europe's foremost experts in healthcare, technology, business strategy and venture capital is in place to help companies deliver on their growth agenda.

Executives from the selected digital health companies will have the opportunity to enjoy the benefits of a growth-focused curriculum, expert advice, and close interaction with venture and angel financing partners. Launched in July, in partnership with Health 2.0, the Masterclass offers an opportunity for executives to take their businesses to the next level and to raise their profile with key influencers in the field of digital health.

The programme modules will include:

Session 1, Berlin - September 18th to 20th 2013

  • Clear evidence-based case for healthcare transformation and digital health
  • Detailed look at G5 Healthcare markets & innovation programmes
  • Examination of regulatory issues and compliance for digital health companies
  • Strategy Exercise- identifying core capabilities required to maintain strategic advantage

Session 2, Barcelona - October 9th to 11th 2013

  • Business model development, excercise, and expert review
  • Developing detailed growth-focused business models and related operational plans
  • Deep dive on technology and trends in each of the primary Digital Health technology verticals
  • Introduction on scaling business operations

Session 3, London - October 28th to 30th 2013

  • Scaling product and service delivery
  • Developing trials and data sets to support "evidence based" sales
  • Building executive teams, boards, and advisors that can help you scale
  • Power of Story- build a powerful company story that connects with investors and customers
  • Financing your company's growth

The programme will culminate in an Investor Day on November 20th in London, run in partnership with local venture capitalists, healthcare providers and technology companies, the day will also provide significant networking opportunities. All companies will be able to meet and to forge their own relationships directly with prospective investors and customers.

9th of August is the closing date for applications - successful applicants will not only have the opportunity to share a prize pool of €50k, they will also have a rare chance to interact with leading voices from business, healthcare, and technology.

Format: Companies selected for the Masterclass will attend a series of three 3-day workshops run in partnership with local healthcare and technology companies. Networking sessions will be held in the evening at each location

Dates: September 18th to November 20th

Workshops: European locations, finishing in London.

Challenge and Investor Day, London - 20th November 2013 in association with Health 2.0 Europe

For further information, please visit:
http://masterclass.jnjinnovation.com

Related news article:

Most Popular Now

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Digital ECGs at Barts Health: A High-Imp…

Opinion Article by Dr Krishnaraj Sinhji Rathod, consultant in interventional cardiology, Barts Health NHS Trust. Picture the moment. A patient in an ambulance, enroute to hospital with new chest pain. Paramedics...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

Study Sheds Light on Hurdles Faced in Tr…

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools...

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

New AI Approach Paves Way for Smarter T-…

Researchers have harnessed the power of artificial intelligence (AI) to tackle one of the most complex challenges in immunology: predicting how T cells recognize and respond to specific peptide antigens...

Study Used AI Models to Improve Predicti…

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD). Globally, the prevalence of the...

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...